India’s most populous state of Uttar Pradesh will spend up to $1 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local distributor of Russia’s Sputnik V, a state official said on Thursday.
The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe shortages amid a record surge in coronavirus infections, with India recording more than 4,000 deaths for a second straight day as its health system fails to cope.
Read the latest updates in our dedicated coronavirus section.
Uttar Pradesh has also held pre-bid talks with Indian vaccine companiesthe Serum Institute of India -- licensed to make the AstraZeneca and Novavax shots -- Bharat Biotech and Cadila Healthcare as part of a global tender to buy 40 million doses over the next few months, state spokesman Navneet Sehgal told Reuters.
For the latest headlines, follow our Google News channel online or via the app.
He said Johnson and Johnson could also confirm their participation in the tender by late Thursday via email. Sputnik V’s local distributor, Dr. Reddy’s Laboratories, has also held talks.
“Money is not an issue, we have a huge budget,” said Sehgal, a senior bureaucrat in the state of 240 million people. “We will spend up to 100 billion rupees ($1.36 billion).”
He however said funds would have to be diverted from other areas to buy the vaccines.
Covid-hit India welcomes Gulf medical aid, boosts oil imports from Saudi Aramco
India doctors warn of deadly rare fungal infection in COVID-19 patients
Egypt’s Eva Pharma to provide India with 300,000 doses of COVID-19 drug remdesivir
More than 4,000 Indians die of COVID-19 for second straight dayIndia recorded more than 4,000 COVID-19 deaths for a second straight day on Thursday, while infections stayed below 400,000 for a fourth day, though ... Coronavirus
Russia records first cases of Indian COVID-19 variant: ReportsRussia has recorded its first cases of the variant of COVID-19 first found in India, Kommersant newspaper reported on Thursday, citing authorities in ... Coronavirus
Scientists race to study COVID-19 variants in India as cases explodeA potentially worrisome variant of the coronavirus detected in India may spread more easily. But the country is behind in doing the kind of testing ... Coronavirus
India’s COVID-19 death toll passes 250,000: Official dataIndia said on Wednesday a record number of people were killed by the coronavirus in the past 24 hours, pushing its overall death toll over a quarter ... Coronavirus
India PM Modi not to attend G7 Summit in UK ‘in person’ due to COVID situation: GovtPrime Minister Narendra Modi will not attend the G7 Summit in the UK in person, the foreign ministry said Tuesday, as India reels from a massive wave ... World News
India’s seven-day COVID-19 average at new high, WHO issues warning on strainIndia’s coronavirus crisis showed scant sign of easing on Tuesday, with a seven-day average of new cases at a record high and international health ... Coronavirus
India doctors warn of deadly rare fungal infection in COVID-19 patientsA growing number of current and recovered COVID-19 patients in India are contracting a deadly and rare fungal infection, doctors told AFP Monday as ... Coronavirus
Egypt’s Eva Pharma to provide India with 300,000 doses of COVID-19 drug remdesivirEgypt’s Eva Pharma on Monday signed an agreement to provide India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company ... Coronavirus
Covid-hit India welcomes Gulf medical aid, boosts oil imports from Saudi AramcoIndian oil minister Dharmendra Pradhan on Friday thanked Saudi Arabia and other Middle Eastern oil producers for supplying liquid medical oxygen (LMO) ... Coronavirus